Login / Signup

Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use.

Andrew P McGovernMichael FeherNeil MunroSimon de Lusignan
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2017)
AstraZeneca.
Keyphrases
  • phase iii
  • study protocol
  • electronic health record
  • phase ii
  • clinical trial
  • big data
  • open label